Welcome, Guest. Please login or register.
September 26, 2023, 04:27:17 am

Login with username, password and session length

  • Total Posts: 55101
  • Total Topics: 4848
  • Online Today: 49
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 15
Total: 15


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: NASH May Soon Be the No. 1 Cause of Liver Transplants in the U.S.  (Read 7342 times)

0 Members and 1 Guest are viewing this topic.

Offline iana5252

  • Administrator
  • Member
  • Posts: 185
NASH May Soon Be the No. 1 Cause of Liver Transplants in the U.S.
« on: September 15, 2015, 04:58:46 pm »
Over the next 10 to 20 years, nonalcoholic steatohepatitis (NASH), a form of obesity-related fatty liver disease, could overtake the hepatitis C virus (HCV) as the leading indication for a liver transplant in the United States.

Liver disease researchers say incidence of NASH has steadily risen in the United States during the past decade, as obesity rates continue to skyrocket. The condition is characterized by liver inflammation, and if left to its own devices without a transplant, it can ultimately cause cirrhosis, liver fibrosis and even liver cancer. Other than weight loss, there is no effective treatment for NASH.



© 2023 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.